Business Standard

Monday, December 23, 2024 | 03:57 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Strong medicine

Patanjali ad ban is the right remedy

Patanjali store
Premium

Business Standard Editorial Comment Mumbai

Listen to This Article

The Supreme Court has administered a strong antidote to the chronic problem of misleading medical advertising by restraining Patanjali Ayurved from advertising or marketing its products until further orders. The court has also issued contempt notices to the company’s founder Baba Ramdev and Managing Director Acharya Balkrishna for ignoring previous orders against publishing misleading claims. The allegations against Patanjali were filed by the Indian Medical Association (IMA) in August 2022, following a prominent ad campaign by Patanjali, detailing “misconceptions” spread by the pharma and allopathy industry. Elsewhere, Mr Ramdev, who is a popular and politically influential yoga instructor, had publicly

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in